Patents by Inventor Yao Jing

Yao Jing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
    Publication number: 20210380559
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Application
    Filed: August 17, 2021
    Publication date: December 9, 2021
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing
  • Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses
    Patent number: 11117882
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: September 14, 2021
    Assignee: Emory University
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing
  • GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor
    Publication number: 20210017149
    Abstract: A compound according to Formula (I) or salts or prodrugs thereof and pharmaceutical formulations comprising the compound are provided herein for the treatment of neurological disorders. The disorders may include providing neuroprotection, preventing neurodegeneration, treating neuropathic pain or treating schizophrenia, psychoses or depression.
    Type: Application
    Filed: March 28, 2019
    Publication date: January 21, 2021
    Inventors: Dennis Liotta, Stephen Traynelis, Yao Jing
  • Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
    Publication number: 20180346445
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Application
    Filed: August 2, 2018
    Publication date: December 6, 2018
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing